Dual-hormone fully closed-loop therapy versus multiple daily insulin injections or hybrid closed-loop therapy in adults with type 1 diabetes: a multicentre, open-label, randomised controlled trial
Authors:
- Milena JancevMJMilena Jancev
- Frank J. SnoekFSFrank J. Snoek
- Miriam P. van der MeulenMMMiriam P. van der Meulen
- Heleen C. KnottnerusHKHeleen C. Knottnerus
- Lyan B. VlaskampLVLyan B. Vlaskamp
- Maureen F.T. WitkopMWMaureen F.T. Witkop
- Karel G.M. MoonsKMKarel G.M. Moons
- Harold W. de ValkHVHarold W. de Valk
- Arianne C. van BonABArianne C. van Bon
- J. Hans DeVriesJDJ. Hans DeVries
- Erik H. SernéESErik H. Serné
- Thomas T. van SlotenTSThomas T. van Sloten
Open Access
- 1 October 2026
- journal article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 70
Abstract
No abstract availableFunding Information
- Zorginstituut Nederland
- ZonMw
This publication has 16 references indexed in Scilit:
- Trends and Disparities in Technology Use and Glycemic Control in Type 1 DiabetesJAMA Network Open, 2025
- Fully automated insulin delivery systems in type 1 diabetes: A systematic review and meta‐analysisDiabetes, Obesity and Metabolism, 2025
- The role of automated insulin delivery technology in diabetesDiabetologia, 2024
- Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the NetherlandsThe Lancet Digital Health, 2024
- Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record DataCanadian Journal of Diabetes, 2023
- Exercise in adults with type 1 diabetes mellitusNature Reviews Endocrinology, 2022
- Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysisDiabetes, Obesity and Metabolism, 2022
- International comparison of glycaemic control in people with type 1 diabetes: an update and extensionDiabetic Medicine, 2021
- Outpatient 60‐hour day‐and‐night glucose control with dual‐hormone artificial pancreas, single‐hormone artificial pancreas, or sensor‐augmented pump therapy in adults with type 1 diabetes: A n open‐label, randomised, crossover, controlled trialDiabetes, Obesity and Metabolism, 2017
- Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at homeDiabetes, Obesity and Metabolism, 2016